♟️ Friday 31 January 2025 Fri, 31 Jan 2025

Jindalee Lithium’s latest quarterly report confirms a 63-year life for its McDermitt Lithium Project, underpinned by robust financial metrics and a maiden ore reserve that taps just a fraction of its vast resource.

Larvotto Resources has reported robust progress at its Hillgrove Antimony-Gold Project, highlighted by exceptional drilling results and a successful $30 million capital raise, positioning the company for production by late 2025.

Cleo Diagnostics reports steady progress in its U.S. and Australian clinical trials for an ovarian cancer blood test, maintaining a solid cash reserve of A$7.3 million as it prepares for FDA submission.

Great Northern Minerals Limited reports significant progress in the sale of its Golden Ant Mining project, with a $1.3 million Earn-In Stage payment expected soon, alongside notable board changes and strategic project reviews.

South Harz Potash Limited has made significant strides in acquiring the Sollstedt mine and secured approximately A$2.2 million in new equity, positioning itself to advance the Ohmgebirge project amid a strengthening potash market.

Red Sky Energy's December 2024 report reveals steady production from Yarrow 3, imminent fracture stimulation at Yarrow 1, and a transformative 35% stake in Angola's Block 6/24, positioning the company for diversified growth and enhanced cash flow.

Prescient Therapeutics has secured FDA clearance for its PTX-100 Phase 2 trial targeting relapsed/refractory cutaneous T-cell lymphoma, while also appointing James McDonnell as its new CEO. The company reports steady progress in its cell therapy platforms and maintains a solid cash position bolstered by a recent R&D tax rebate.

High-Tech Metals Limited intensifies its exploration efforts at the Werner Lake Project in Canada while appointing Warren Thorne as CEO to spearhead growth and asset acquisition strategies.

Bayan Mining and Minerals advances its exploration footprint with 158 new claims in Nevada, completes key desktop studies, and strategically withdraws from its Canadian Tango Lithium Project.

Alexium International Group reports a 16% sales increase in Q2 FY25 despite ongoing mattress market softness, driven by strategic product diversification and supply chain improvements.

Range International Limited has appointed Russell Kennett as its new CEO, marking a pivotal step in the company’s growth strategy. The move comes alongside an update to Executive Chairman Richard Jenkins’ remuneration, underscoring leadership continuity.

Epsilon Healthcare's December 2023 quarterly report reveals significant boardroom conflict and governance breaches, yet operational segments show promising growth.

Epsilon Healthcare Limited reported a modest cash increase in its December quarter but remains under administration with no unused financing facilities, raising questions about its operational future.

LCL Resources has executed a binding agreement to divest its Colombian assets for A$10 million, while confirming a significant copper-gold porphyry discovery at its Dada project in Papua New Guinea.

Alligator Energy reports significant progress across its uranium portfolio, including regulatory milestones at Samphire and promising drilling results at Big Lake and Nabarlek North, supported by a solid cash position of $20.2 million.

Accelerate Resources has secured a 70% stake in the Kanowna East Gold Project near Kalgoorlie and raised $1.35 million to accelerate exploration, while also identifying lithium-bearing spodumene at Mt Sholl East.

GWR Group Limited reports completion of phase two drilling at its Prospect Ridge Magnesium Project with assay results pending, while divesting its Hatches Creek interest to bolster focus and capital for growth.

Echo IQ confirms the material significance of its pre-submission FDA meeting for EchoSolv HF, marking a pivotal step toward US market entry and commercialisation.

Strata Minerals Limited has identified four significant drill targets at its Penny South Gold Project in WA and is set to commence its maiden drilling program in February 2025, signaling a major step forward in its exploration strategy.

Wellnex Life Limited reported a 36% rise in Q2 FY25 cash receipts and record monthly sales, while advancing its dual listing on the London Stock Exchange and expanding into the UK market.

Saferoads Holdings reported a slight revenue dip in Q2 2024 but advanced toward selling its Road Safety Rentals business, while securing approval for a new crash barrier system.

Provaris Energy has achieved a major breakthrough with a term sheet for green hydrogen supply to Uniper, marking Europe's first large-scale regional hydrogen marine transport project. Concurrently, the company is advancing innovative CO2 tank designs in partnership with Yinson, positioning itself at the forefront of energy transition infrastructure.

Eagle Mountain Mining has strengthened its Silver Mountain copper project prospects, initiated tailings repurposing at Wedgetail, and launched a capital raise to reduce debt, while relinquishing Oracle Ridge mineral rights due to unaligned landowner terms.

Cambium Bio has secured a A$3 million capital raise and achieved FDA Fast Track status for its lead ophthalmology product, Elate Ocular®, setting the stage for Phase 3 trials in mid-2025.